Trial intelligence / Profile preview

Phase II single-arm study of liposomal irinotecan plus fruquintinib in third-line or later advanced colorectal cancer

ChiCTR2600135181Phase 2Not yet recruiting

Sponsor

Cancer Hospital of Guangxi Medical University

Start

Nov 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1